Ron Bentsur - Mar 23, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Mar 23, 2023
Transactions value $
$2,790
Form type
4
Date filed
3/27/2023, 08:21 AM
Previous filing
Mar 23, 2023
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $2.79K +230 +0.01% $12.13 3.23M Mar 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 330,000 restricted stock units.